Kevin Munoz - 29 Dec 2021 Form 4 Insider Report for Silo Pharma, Inc. (SILO)

Role
Director
Signature
/s/ Kevin Munoz
Issuer symbol
SILO
Transactions as of
29 Dec 2021
Net transactions value
$0
Form type
4
Filing time
03 Jan 2022, 20:55:14 UTC
Next filing
27 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILO Non-Qualified Stock Option Award $0 +171,233 $0.000000 171,233 29 Dec 2021 Common Stock 171,233 $0.1460 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests over the course of one year from grant with 100% vesting a year from the date of grant.
F2 The options were issued under the issuer's 2020 Omnibus Equity Incentive Plan.